Two NIH program officers join us in this NIH All About Grants podcast to discuss what should be considered when deciding whether or not to resubmit an application.
My resubmission of a competing renewal application (Type 2 A1) was not funded. May I submit a new renewal (Type 2 A0)?
No. Only a single resubmission of a competing new, revision, or renewal application (A0) will be accepted. After a resubmission of a competing renewal (Type 2) application that is not funded, a subsequent new renewal (Type 2 A0) application may not be submitted. The next application submitted on this topic should be submitted as a new application (Type 1 A0) on an appropriate due date for new applications (see NOT-OD-18-197 for exceptions).
The NIH Center for Scientific Review and National Institute of Mental Health will no longer offer a special deadline for new investigator resubmission applications. This change goes into effect starting with R01 applications submitted for due dates on or after January 25, 2019.
It depends on whether the FOAs are Program Announcements (PA, PAR, PAS or Parent) or Requests for Applications (RFA).
When applicants receive their summary statement resulting from the review of an application that was assigned a score outside of the ICs funding range, there are important decisions to be made that, ideally, should be based upon evidence. What is the likelihood that an application like this one will be funded? If I resubmit the application, what changes might improve the chances for a successful resubmission?
Recall that in 2014, NIH relaxed its resubmission policy (OD-14-074) to allow applicants to submit a new (A0) application following an unsuccessful resubmission application. Also, we recently posted a piece showing that review outcomes for new applications submitted following an unsuccessful resubmission had about the same funding success as other new applications. But some applicants may wonder, what is the funding success for a resubmission application? ….
A few months ago, a researcher told me about his experiences with the relatively new NIH policy by which investigators are allowed to submit what we have come to call “virtual A2s.” Under NIH’s previous single resubmission policy, if an investigator’s de novo R01 grant application (called an “A0”) was not funded, they had one chance to submit a revision (called an “A1”). If the A1 application was unsuccessful, the applicant was required to make significant changes in the application compared to the previous submissions. NIH took measures to turn away subsequent submissions that were materially similar to the unfunded A1. Under NIH’s current policy, investigators may resubmit a materially similar application as a new submission after the A1 submission. We will call these applications “virtual A2s.” The researcher told me that his virtual A2 did not fare well; although his A0 and A1 had received good scores (though not good enough for funding), the virtual A2 was not discussed. He wondered, just how likely is it for a virtual A2 to be successful? ….